INBS files 510(k) with FDA for fingerprint sweat drug test; 94.1% accuracy, 2025 US launch target

INTELLIGENT BIO SOLUTIONS INC.

510(k) submission for Intelligent Fingerprinting Drug Screening System; method comparison study showed 94.1% accuracy.
PK study demonstrated fingerprint sweat drug detection closely aligned to blood at 95% confidence level.
System provides non-invasive results within 10 minutes; already adopted in international markets.
US market entry planned for 2025; targets safety-critical industries (construction, mining, transportation).
Potential applications in law enforcement, drug rehabilitation, and forensic sectors for diverse revenue streams.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.